Jiaqi Hu
-
- Lung Cancer Treatments and Mutations 6
-
- Peptidase Inhibition and Analysis 3
- HER2/EGFR in Cancer Research 3
- Pancreatic and Hepatic Oncology Research 2
-
- Cancer therapeutics and mechanisms 3
- Ginseng Biological Effects and Applications 2
-
- Oral Health Pathology and Treatment 2
-
- Mycobacterium research and diagnosis 2
- Co-authors
- Honggang ZhengRui LiuBaojin HuaShuntai ChenQiujun GuoXing ZhangMeng LiYupeng Xi
- Journals
- Frontiers in Oncology (4 papers)Frontiers in Pharmacology (4 papers)Journal of Oral Pathology and Medicine (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Jiaqi Hu
37 papers receiving 609 citations
Peers
Comparison fields: 5 of 99
- Pulmonary and Respiratory Medicine 229
- Oncology 191
- Cancer Research 81
- Gastroenterology 24
- Surgery 185
Countries citing papers authored by Jiaqi Hu
This map shows the geographic impact of Jiaqi Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaqi Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaqi Hu more than expected).
Fields of papers citing papers by Jiaqi Hu
This network shows the impact of papers produced by Jiaqi Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaqi Hu. The network helps show where Jiaqi Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiaqi Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 10 | |
| 5 | 2023 | 28 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 26 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 4 | |
| 11 | 2022 | 7 | |
| 12 | 2021 | 14 | |
| 13 | 2021 | 16 | |
| 14 | 2021 | 20 | |
| 15 | 2021 | 6 | |
| 16 | 2021 | 10 | |
| 17 | 2019 | 8 | |
| 18 | 2018 | 21 | |
| 19 | 2010 | 17 | |
| 20 | 1995 | 11 |
About Jiaqi Hu
Jiaqi Hu is a scholar working on Oncology, Periodontics and Pharmacy, having authored 39 papers that have together received 619 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Cancer therapeutics and mechanisms (3 papers), Peptidase Inhibition and Analysis (3 papers), HER2/EGFR in Cancer Research (3 papers), Oral Health Pathology and Treatment (2 papers), Ginseng Biological Effects and Applications (2 papers), Mycobacterium research and diagnosis (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (229 citations), Oncology (191 citations) and Cancer Research (81 citations). Jiaqi Hu has collaborated with scholars based in China and United States. Frequent co-authors include Honggang Zheng, Rui Liu, Baojin Hua, Shuntai Chen, Qiujun Guo, Xing Zhang, Meng Li, Yupeng Xi, Yuan Yuan and Zhichao Jin. Their work appears in journals such as Frontiers in Oncology, Frontiers in Pharmacology, Journal of Oral Pathology and Medicine, International Journal of Surgery and Geotechnical and Geological Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.